$2.30
▲ +5.0% Today
as of Oct 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026
Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
XAIR earnings at a glance
Over its last 1 reports the stock rose the next day 1 time and fell 0, moving ±58.3% on average; after the most recent report on Jun 17, 2025 it moved +58.3%. XAIR beat the consensus EPS estimate in 1 of its last 3 reported quarters. The share price of $2.30 sits near its 52-week low.
Overview
52-week range
$2.05
$53
0% of range
Avg surprise (last 3)
-6.2%
Avg reaction (last 1)
+58.3%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-11.00 | — | — | — | — | financials |
| Wed Dec 31, 2025 | Dec 2025 | $-0.85 | — | — | — | — | financials |
| Mon Nov 10, 2025 | Sep/2025 | $-1.25 | — | — | — | — | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-1.53 | $-1.50 | -2.0% | — | — | earnings |
| Tue Jun 17, 2025 | Mar/2025 | $-0.09 | $-0.14 | +35.7% | — | +58.3% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-2.96 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-5.67 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-5.32 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.50 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.51 | — | — | — | — | financials |
| Thu Jun 22, 2023 | Mar/2023 | $-0.67 | $-0.44 | -52.3% | — | — | earnings |
| Sat Dec 31, 2022 | Dec 2022 | $-0.43 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | — | $2M | $2M | $2M | — | $1M | $798,000 |
| Cost of revenue | $2M | — | $2M | $2M | $2M | — | $1M | $2M |
| Gross profit | $225,000 | — | $300,000 | $-298,000 | $156,000 | — | $-215,000 | $-1M |
| Operating income | $-7M | — | $-7M | $-8M | $-8M | — | $-11M | $-13M |
| Net income | $-8M | — | $-7M | $-8M | $-8M | — | $-13M | $-14M |
| EPS (diluted) | $-11.00 | — | $-0.85 | $-1.25 | $-30.67 | — | $-2.96 | $-5.67 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6M | $7M | $7M | $10M | $5M | $5M | $5M | $28M |
| Inventory | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M |
| Total current assets | $23M | $25M | $26M | $19M | $15M | $16M | $19M | $38M |
| Total assets | $33M | $35M | $37M | $31M | $28M | $30M | $34M | $53M |
| Long-term debt | — | — | — | — | — | — | $12M | $12M |
| Total liabilities | $30M | $29M | $28M | $18M | $18M | $16M | $16M | $24M |
| Total equity | $2M | $6M | $8M | $13M | $10M | $14M | $18M | $29M |
Implied volatility — last 90 days
No IV snapshots yet for XAIR.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
XAIR earnings FAQ
How does XAIR stock usually react to earnings?
Across the last 1 reports the average next-day move was ±58.3%, up 1 times and down 0 times.